Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Reflux esophagitis.

G N Tytgat1, C Y Nio, R H Schotborgh

  • 1Gastroenterology Dept., University of Amsterdam, The Netherlands.

Scandinavian Journal of Gastroenterology. Supplement
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Radiofrequency ablation and chemotherapy versus chemotherapy alone for locally advanced pancreatic cancer (PELICAN): study protocol for a randomized controlled trial.

Trials·2021
Same author

IMARI: multi-Interventional program for prevention and early Management of Anastomotic leakage after low anterior resection in Rectal cancer patIents: rationale and study protocol.

BMC surgery·2020
Same author

Evaluation of compressed sensing MRI for accelerated bowel motility imaging.

European radiology experimental·2019
Same author

Predictive factors on CT imaging for progression of uncomplicated into complicated acute diverticulitis.

International journal of colorectal disease·2017
Same author

Nationwide outcomes in patients undergoing surgical exploration without resection for pancreatic cancer.

The British journal of surgery·2017
Same author

The development of a magnetic resonance imaging index for fistulising Crohn's disease.

Alimentary pharmacology & therapeutics·2017
Same journal

Abstract from the 41st Nordic Gastroenterology Congress, 8-11 June 2010, Copenhagen, Denmark.

Scandinavian journal of gastroenterology. Supplement·2010
Same journal

Abstracts from the XL Nordic Meeting of Gastroenterology, June 8-11, 2009, Stavanger, Norway.

Scandinavian journal of gastroenterology. Supplement·2009
Same journal

Abstracts of the 39th Nordic Meeting of Gastroenterology, 30th Nordic Meeting of Digestive Endoscopy, 18th Nordic Meeting of Gastrointestinal Motility, and the Annual Endoscopy/Gastroenterology Nurses'/Assistants' Meeting Post-graduate course, 4-6 June 2008, Helsinki, Finland.

Scandinavian journal of gastroenterology. Supplement·2008
Same journal

Abstracts from the XXXVIII Nordic Meeting of Gastroenterology, XXIX Nordic Meeting of Digestive Endoscopy, XVII Nordic Meeting of Gastrointestinal Motility, 6-9 June 2007, Reykjavik, Iceland.

Scandinavian journal of gastroenterology. Supplement·2007
Same journal

Abstracts of the XXXVII Nordic Meeting of Gastroenterology, 3-5 May 2006, Vasteras, Sweden.

Scandinavian journal of gastroenterology. Supplement·2006
Same journal

Novel approaches in the outpatient care of patients with chronic inflammatory bowel disease.

Scandinavian journal of gastroenterology. Supplement·2006
See all related articles

Effective reflux esophagitis treatment involves managing gastric acid and emptying. High-dose H2-receptor antagonists and omeprazole offer rapid relief, while long-term therapy is crucial for sustained remission.

Area of Science:

  • Gastroenterology
  • Pharmacology

Background:

  • Reflux esophagitis management requires addressing multiple factors including antireflux barrier competence, esophageal clearance, gastric emptying, and gastric content properties.
  • Current therapeutic strategies aim to reduce the volume and acidity (pH) of gastric contents.

Purpose of the Study:

  • To review and synthesize the efficacy of various therapeutic approaches for reflux esophagitis.
  • To evaluate the effectiveness of different drug classes and dosing regimens in achieving symptom relief and healing.

Main Methods:

  • Literature review and analysis of clinical data on therapeutic agents for reflux esophagitis.
  • Comparison of single-agent therapies, combination therapies, and different dosing strategies (e.g., post-evening meal vs. twice daily).

Related Experiment Videos

Main Results:

  • Cisapride is the only prokinetic agent with proven benefit.
  • Conventional-dose H2-receptor antagonists and sucralfate show similar efficacy for symptom relief and healing.
  • High-dose H2-receptor antagonists and omeprazole provide more rapid symptom relief and healing.
  • Twice-daily dosing of H2-receptor antagonists is superior to once-daily dosing for symptomatic response.

Conclusions:

  • Long-term therapy is necessary for sustained remission, utilizing high-dose H2-receptor antagonists, cisapride, or sucralfate.
  • Long-term omeprazole is a viable option for elderly or complicated cases.
  • The clinical significance of sustained hypo- or achlorhydria requires further investigation.